Who may be considered
Eligibility depends on current FDA labeling, BMI, weight-related conditions, prior treatment, medications and risks. A prescriber must confirm that benefits outweigh risks and that the product and indication are appropriate.
Home / Treatment Library / Semaglutide for Medical Weight Management
GLP-1 weight management
Semaglutide for Medical Weight Management
Evidence-based, physician supervised. A clear, evidence-aware guide to candidacy, treatment, recovery, limitations and next steps.
Evidence reviewed September 3, 2026
SettingIn-office treatment
PricingConsultation required
Provider reviewIndividualized
Healthy change
A plan built around your body—not a template
Physician-led guidance brings your goals, health history and realistic expectations into one thoughtful plan.
The short answer
What is Semaglutide for Medical Weight Management?
Semaglutide is a GLP-1 receptor agonist. FDA-approved Wegovy products are indicated for chronic weight management in eligible patients alongside reduced-calorie nutrition and increased physical activity, with additional labeled cardiovascular and liver-related indications depending on the current product labeling.
Concerns it may address
- Obesity or overweight with qualifying weight-related conditions
- Appetite regulation and sustained weight-management support
- Cardiometabolic risk that warrants comprehensive medical care
- Patients prepared for long-term behavior change and monitoring
Candidacy
Who may—or may not—be a candidate
When treatment may not be appropriate
Semaglutide is contraindicated with a personal or family history of medullary thyroid carcinoma or MEN 2 and with serious hypersensitivity to semaglutide. Pregnancy, pancreatitis history, severe gastrointestinal disease, gallbladder disease, diabetic retinopathy and interacting diabetes medicines require careful review.
At a glance
Treatment facts
These are practical planning ranges, not promises. Your consultation determines the exact plan.
- Treatment time
- Initial visit about 30–60 minutes; follow-ups are shorter
- Comfort / anesthesia
- Weekly injection or other FDA-approved formulation as prescribed
- Typical downtime
- No procedural downtime; gastrointestinal effects can limit activity
- When changes may appear
- Appetite or weight change evolves over weeks to months
- How long results may last
- Long-term treatment may be needed; weight regain can occur after stopping
- Treatments commonly considered
- Ongoing titration and monitoring, not a short fixed series
Your visit
What happens during treatment
Evaluate
The clinician reviews weight history, health conditions, medications, pregnancy plans and prior attempts, and orders appropriate labs.
Plan & treat
If eligible, an FDA-approved product is prescribed when accessible and clinically appropriate. Dose escalation follows product labeling and tolerability.
Review & follow up
Nutrition, activity, adverse effects and objective outcomes are monitored. Treatment is changed or stopped when risks, intolerance or lack of benefit outweigh benefit.
Informed choice
Important risks, limitations and alternatives
Risks & limitations
Common effects include nausea, vomiting, diarrhea, constipation and abdominal pain. Important risks include pancreatitis, gallbladder disease, dehydration-related kidney injury, severe gastrointestinal reactions, allergic reaction and low blood sugar with certain diabetes drugs. Current labeling includes a boxed warning related to thyroid C-cell tumors.
Alternatives to discuss
- Intensive lifestyle and nutrition treatment
- Another FDA-approved anti-obesity medication
- Tirzepatide when clinically appropriate
- Bariatric-surgery evaluation for eligible patients
Clinical judgment
Why provider experience matters
Prescribing is only one part of safe obesity care. Experienced medical oversight verifies the product source, screens contraindications, manages titration and side effects, preserves lean mass and monitors when treatment should change.
Identity Aesthetics approach
- Diagnosis and anatomy before a product or device
- Conservative planning with candid limitations
- Licensed-provider supervision and complication readiness
- In-office and telehealth boundaries stated clearly
Access & cost
In-office versus telehealth
Consultations and follow-up may be in-office or by telehealth for patients physically located in Texas, North Carolina or South Carolina, subject to eligibility and law. Labs or in-person assessment may be required.
Pricing: Consultation required. Medication price varies by FDA-approved product, insurance coverage, pharmacy and dose. Identity Aesthetics does not promise coverage or a fixed medication cost.
Medication transparency
Verify the pharmacy before treatment
When a prescription or compounded preparation is clinically appropriate, the dispensing pharmacy, facility classification and current license status matter. Compounded medications are not FDA-approved drug products.
Common questions
Semaglutide for Medical Weight Management FAQ
Is compounded semaglutide FDA approved?
No. Compounded drugs are not FDA-approved. They may be used only under applicable law and patient-specific clinical circumstances; FDA has warned about dosing errors, quality concerns and products using different salt forms.
Will I regain weight if I stop?
Weight regain is common after stopping anti-obesity medication. Long-term planning should be discussed before starting.
Can I use Ozempic for weight loss?
Ozempic is approved for type 2 diabetes indications, while Wegovy products carry weight-management indications. Product selection must follow diagnosis, labeling and clinician judgment.
Sources & medical review
- FDA Prescribing Information — Wegovy (semaglutide)
- FDA — Concerns With Unapproved GLP-1 Drugs Used for Weight Loss
Medical-content evidence review: September 3, 2026. Content is written for patient education and structured from current primary regulatory, labeling and professional sources. It has not been individualized to your medical history. Product labeling and guidance can change; a licensed Identity Aesthetics provider confirms current suitability, informed consent and treatment details before care.
Your next step
Make an informed plan
Bring your goals, questions, medication list and prior treatment history. We will help you decide whether Semaglutide for Medical Weight Management—or an alternative—makes sense.